Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Rutgers’ Promising Malaria Drug Starting Human Clinical Trials Medical Countermeasures March 7, 2016 …
Antibiotic Resistant Bacteria Countermeasure Accelerator Antimicrobial Resistance February 23, 2016 …
Government, Pharma Leaders to Gather at Superbugs & Superdrugs Antimicrobial Resistance February 21, 2016 …
